Sfoglia per AUTORE
LUNGHI M
Collezione AOU Novara

  

Items : 29

Long-term survival can be achieved in a significant fraction of older patients with core-binding factor acute myeloid leukemia treated with intensive chemotherapy. in Haematologica / Haematologica. 2025 Mar 1;110(3):608-620. doi: 10.3324/haematol.2024.285448.

2025
AOU Città della Salute di Torino
AOU Novara

Huls G; Valent P; Eisfeld AK; Albano F; Visani G; DiBona E; Roti G; Rigolin GM; Marvalle D; Audisio E; Festuccia M; Venditti A; Forghieri F; Galimberti S; Lanza F; Pullarkat S; Lunghi M; Gotlib JR; Candoni A; Capelli D; Deeg HJ; Gurrieri C; Yeung CCS; Cairoli R; Morgan EA; Ferrara F; Marcucci G; Papayannidis C; Tecchio C; et alii...

Outcomes of allogeneic stem cell transplant in adult Philadelphia negative acute lymphoblastic leukemia patients treated with the pediatric-inspired GIMEMA 1913 protocol. A Campus ALL study. in Bone marrow transplantation / Bone Marrow Transplant. 2025 Jun 2. doi: 10.1038/s41409-025-02632-z.

2025
AOU Novara

Cavallaro G; Lazzarotto D; Pavoni C; Valsecchi F; Grassi A; Papayannidis C; Cerrano M; Fracchiolla N; Giglio F; Dargenio M; Lunghi M; Imbergamo S; Del Principe MI; Trappolini S; Fumagalli M; Zappasodi P; Salutari P; Delia M; Pasciolla C; Mosna F; Scappini B; Forghieri F; Chiusolo P; Skert C; Cambò B; Defina M; Lanzarone G; Mauro E; Bonifacio M; et alii...

Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study. in Haematologica / Haematologica. 2025 Jan 1;110(1):55-67. doi: 10.3324/haematol.2024.285638.

2025
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Candoni A; Foa R; Ferrara F; Pizzolo G; Bassan R; Starza ID; Fanin R; Luppi M; Marsili G; Vignetti M; Piciocchi A; Mancini V; De Bellis E; Trastulli F; Ciccone M; De Gobbi M; Cignetti A; Mazzone C; Aprile L; Mauro E; Fanin M; Chiusolo P; Minetto P; Defina M; Delia M; Pasciolla C; Grimaldi F; Cambo B; Santoro L; et alii...

Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies. in Vaccines / Vaccines (Basel). 2025 Apr 16;13(4):419. doi: 10.3390/vaccines13040419.

2025
AOU Novara

Sicuranza A; Breccia M; Iuliano F; Gugliotta G; Castagnetti F; Lunghi M; Patriarca A; Intermesoli T; Luciano L; Russo Rossi A; Rege Cambrin G; Vucinic V; Malagola M; Malato A; Abruzzese E; D'Adda M; Galimberti S; Defina M; Sammartano V; Cafarelli C; Cencini E; Cartocci A; Pacelli P; Piciocchi A; Rughini A; Niederwieser D; Bocchia M;

Upfront intensive treatment analysis of the Italian Cohort Study on FLT3-mutated AML patients (FLAM): The impact of a FLT3 inhibitor addition to standard chemotherapy in the real-life setting. in Cancer / Cancer. 2025 Apr 1;131(7):e35824. doi: 10.1002/cncr.35824.

2025
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Marconi G; Petracci E; Valli I; Volpi R; Zamagni F; Mattei A; Ottaviani E; Bochicchio MT; Bocchia M; Todisco E; Cilloni D; Rigolin GM; Giannini MB; Bernardi M; Romani C; Fracchiolla N; Olivieri A; Albano F; Lunghi M; Cambò B; Candoni A; Scappini B; Chiusolo P; Audisio E; Martelli MP; Martinelli G; Mulè A; Papayannidis C; Azzali I; et alii...

Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study. in British journal of haematology / Br J Haematol. 2024 Nov;205(5):1734-1745. doi: 10.1111/bjh.19741. Epub 2024 Sep 23.

2024
AOU Novara

Oganesian A; Keer H; Lübbert M; Sano Y; Santini V; Platzbecker U; Fracchiolla NS; Lunghi M; Mayer J; Arnan M; Keating MM; Krauter J; Metzelder SK; Illes A; Rodríguez-Macías G; Novák J; Del Castillo TB; Geissler K; Koristek Z;

The Italian Multicentric Randomized OPTkIMA Trial on Fixed vs Progressive Intermittent TKI Therapy in CML Elderly Patients: 3-Years of Molecular Response and Quality of Life Monitoring After Completing the Treatment Plan. in Clinical lymphoma, myeloma & leukemia / Clin Lymphoma Myeloma Leuk. 2024 May;24(5):323-331. doi: 10.1016/j.clml.2024.01.008. Epub 2024 Jan 2

2024
AOU Alessandria
AOU San Luigi di Orbassano
AOU Novara

Roccaro AM; Pellizzeri S; Butturini G; Bernardi S; Farina M; Defina M; Russo Rossi A; Russo S; Romano A; Tiribelli M; De Gobbi M; Coppi MR; Corsetti MT; Sancetta R; Rosti G; Lemoli RM; Castagnetti F; Lunghi F; Crugnola M; Ferrari ML; D'Adda M; Lunghi M; Stagno F; Binotto G; Abruzzese E; Bonifacio M; Russo D; Bucelli C; Iurlo A; et alii...

Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2024 Mar 10;42(8):881-885. doi: 10.1200/JCO.23.01075. Epub 2023 Dec 21.

2024
AOU Novara

Foà R; Bassan R; Elia L; Piciocchi A; Soddu S; Messina M; Ferrara F; Lunghi M; Mulè A; Bonifacio M; Fracchiolla N; Salutari P; Fazi P; Guarini A; Rambaldi A; Chiaretti S;

Prescription patterns of venetoclax in acute myeloid leukemia. in Hematological oncology / Hematol Oncol. 2024 Jul;42(4):e3298. doi: 10.1002/hon.3298.

2024
AOU Novara

Patriarca A; Gaidano G; Capelli D; Poloni A; Sciabolacci S; Cardinali V; Pisterna A; Ucciero A; Traversa G; Lunghi M;

Ponatinib alone or with chemo-immunotherapy in heavily pre treated Philadelphia-like acute lymphoblastic leukemia: a CAMPUS ALL real-life study. in Haematologica / Haematologica. 2024 Dec 1;109(12):4095-4099. doi: 10.3324/haematol.2024.285258.

2024
AOU Novara

Di Biase F; Fracchiolla NS; Pierini A; Piccini M; Cardinali V; Salutari P; Lazzarotto D; Giglio F; Mastaglio S; Defina M; Basilico CM; Malfona F; Starza ID; Beldinanzi M; Bellomarino V; Cardinali D; Lunghi M; Kaiser F; Annunziata M; Di Trani M; Foa R; Chiaretti S;

A Rare Case of Life-Threatening Jaundice Caused by Epstein-Barr Virus Infection and Secondary Cold Agglutinin Syndrome Successfully Treated with Rituximab. in International medical case reports journal / Int Med Case Rep J. 2024 Oct 22;17:861-867. doi: 10.2147/IMCRJ.S477296. eCollection 2024.

2024
AOU Novara

Bellia M; Greco M; Lunghi M; Moia R; Gaidano G; Patriarca A;

Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study. in Cancers / Cancers (Basel). 2023 Sep 19;15(18):4623. doi: 10.3390/cancers15184623.

2023
AOU Città della Salute di Torino
AOU Novara

Foà R; Curti A; Passamonti F; Sartor C; Buzzatti E; Barozzi E; De Roberto P; Canzi M; Santoro L; Tagliaferri E; Zappasodi P; Cerrano M; Del Principe MI; Defina M; Todisco E; Gurrieri C; Dargenio M; Bonifacio M; Scappini B; Imovilli A; Lunghi M; Lazzarotto D; Forghieri F; Salutari P; Annunziata M; Giglio F; Chiaretti S; Vitale A; Papayannidis C; et alii...

Venetoclax with Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Survival Data from Real-World Studies. in Cancers / Cancers (Basel). 2023 Sep 18;15(18):4618. doi: 10.3390/cancers15184618.

2023
AOU Novara

Ucciero A; Pagnoni F; Scotti L; Pisterna A; Barone-Adesi F; Gaidano G; Patriarca A; Lunghi M;

Digital droplet PCR for T315I BCR::ABL1 KD mutation assessment in adult Ph-positive acute lymphoblastic leukemia with a minimal residual disease increase. in Leukemia & lymphoma / Leuk Lymphoma. 2023 Nov-Dec;64(11):1884-1887. doi: 10.1080/10428194.2023.2235450. Epub 2023 Jul 15.

2023
AOU San Luigi di Orbassano
AOU Novara

Cardinali V; Intermesoli T; Lunghi M; Fracchiolla NS; Alati C; De Simone M; Della Porta MG; De Gobbi M; Bassan R; Cedrone M; Salutari P; Cola M; Di Trani M; Matarazzo M; Bellomarino V; Della Starza I; Elia L; Ansuinelli M; Beldinanzi M; Cardinali D; Mulè A; Guarini A; Foà R; Chiaretti S;

Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front-line with paediatric-inspired regimens: A retrospective multicentre Campus ALL study. in British journal of haematology / Br J Haematol. 2023 Feb;200(4):440-450. doi: 10.1111/bjh.18537. Epub 2022 Nov 6.

2023
AOU Città della Salute di Torino
AOU Novara

Pizzolo G; Ferrara F; Candoni A; Di Renzo N; Krampera M; Cerrano M; La Starza R; Trappolini S; Imovilli A; Tanasi I; Cedrone M; Pasciolla C; Lazzarotto D; Annunziata M; Del Principe MI; Guolo F; Todisco E; Lunghi M; Scattolin AM; Forghieri F; Defina M; Scappini B; Zappasodi P; Audisio E; Giglio F; Salutari P; Papayannidis C; Fracchiolla NS; Vitale A; et alii...

AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia. in Cancer / Cancer. 2023 Apr 1;129(7):992-1004. doi: 10.1002/cncr.34608. Epub 2023 Jan 24.

2023
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Martinelli G; Rossi G; Volpi R; Sciumè M; Tarella C; Marconi G; Federico V; Romano A; Cardinali V; Gigli F; Roncoroni E; Ferrara F; Maurillo L; Nanni J; Rivellini F; Cascavilla N; Fianchi L; Cilloni D; Lanza F; Abruzzese E; Martini V; Lunghi M; Molteni A; Gottardi M; Salutari P; Cairoli R; Borlenghi E; Basilico CM; Manfra I; et alii...

Comparison between azacitidine and decitabine as front-line therapy in elderly acute myeloid leukemia patients not eligible for intensive chemotherapy. in Leukemia research / Leuk Res. 2023 Apr;127:107040. doi: 10.1016/j.leukres.2023.107040. Epub 2023 Feb 14.

2023
AOU Novara

Maurillo L; Spagnoli A; Candoni A; Papayannidis C; Borlenghi E; Lazzarotto D; Fianchi L; Sciumè M; Zannier ME; Buccisano F; Del Principe MI; Mancini V; Breccia M; Fanin R; Todisco E; Lunghi M; Palmieri R; Fracchiolla N; Musto P; Rossi G; Venditti A;

Levocarnitine supplementation for asparaginase-induced hepatotoxicity in adult acute lymphoblastic leukemia patients: A multicenter observational study of the campus all group. in Leukemia research / Leuk Res. 2022 Nov;122:106963. doi: 10.1016/j.leukres.2022.106963. Epub 2022 Sep 21.

2022
AOU Novara

Defina M; Lazzarotto D; Guolo F; Minetto P; Fracchiolla NS; Giglio F; Forghieri F; Vitale A; Chiaretti S; Papayannidis C; Piccini M; Mulè A; Bocchia M; Leoncin M; Gurrieri C; Aprile L; Lunghi M; Bonifacio M; Pasciolla C; Cerrano M; Fumagalli M; Foà R; Candoni A;

Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study. in Cancer medicine / Cancer Med. 2021 Mar;10(5):1726-1737. doi: 10.1002/cam4.3778. Epub 2021 Feb 16.

2021
AOU Alessandria
AOU San Luigi di Orbassano
AOU Novara

De Vivo A; Baccarani M; Roccaro AM; Polverelli N; Bernardi S; Farina M; Bocchia M; Gandolfi L; Aprile L; Russo S; Russo Rossi A; Tiribelli M; Romano A; Rege Cambrin G; Coppi MR; Corsetti MT; Sancetta R; Lemoli RM; Rosti G; Castagnetti F; Lunghi F; Ferrari ML; Crugnola M; Lunghi M; Binotto G; D'Adda M; Stagno F; Abruzzese E; Bonifacio M; et alii...

Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults. in The New England journal of medicine / N Engl J Med. 2020 Oct 22;383(17):1613-1623. doi: 10.1056/NEJMoa2016272.

2020
AOU Novara

Foà R; Bassan R; Vitale A; Elia L; Piciocchi A; Puzzolo MC; Canichella M; Viero P; Ferrara F; Lunghi M; Fabbiano F; Bonifacio M; Fracchiolla N; Di Bartolomeo P; Mancino A; De Propris MS; Vignetti M; Guarini A; Rambaldi A; Chiaretti S;

Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP. in Blood advances / Blood Adv. 2019 Dec 23;3(24):4280-4290. doi: 10.1182/bloodadvances.2019000865.

2019
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

Soverini S; Vigneri P; Rosti G; Russo D; Saglio G; Castagnetti F; Pane F; Breccia M; Bonifacio M; Tomassetti S; Trabacchi E; Spadano R; Tiribelli M; Stagno F; Sancetta R; Sica S; Rege-Cambrin G; Rupoli S; Salvucci M; Rapezzi D; Pregno P; Palmieri F; Musolino C; Miggiano MC; Montefusco E; Melpignano A; Martino B; Marasca R; Lunghi M; et alii...

Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centers. in American journal of hematology / Am J Hematol. 2018 Sep;93(9):E243-E246. doi: 10.1002/ajh.25212. Epub 2018 Aug 25.

2018
AOU Novara

Barcellini W; Zaninoni A; Fattizzo B; Giannotta JA; Lunghi M; Ferrari A; Leporace AP; Maschio N; Scaramucci L; Cantoni S; Chiurazzi F; Consonni D; Rossi G; De Fabritiis P; Gaidano G; Zanella A; Cortelezzi A;

A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia. in Leukemia / Leukemia. 2018 Feb;32(2):413-418. doi: 10.1038/leu.2017.186. Epub 2017 Jun 13.

2018
AOU Città della Salute di Torino
AOU Novara

Ferrero D; Onida F; Pelizzari A; Finelli C; Terenzi A; Angelucci E; Abdel-Wahab O; Ceccarelli M; Sanna A; Masiera E; Cilloni D; Poloni A; Gioia D; Lunghi M; Zini G; Allione B; Santini V; Saglio G; Figueroa M; Levis A;

Myelodysplastic syndromes with single neutropenia or thrombocytopenia are rarely refractory cytopenias with unilineage dysplasia by World Health Organization 2008 criteria and have favourable prognosis. in British journal of haematology / Br J Haematol. 2016 Dec;175(5):975-979. doi: 10.1111/bjh.13902. Epub 2016 Jan 15.

2016
AOU Novara

Gyan E; Andrieu V; Sanna A; Caille A; Schemenau J; Sudaka I; Siguret V; Malet M; Park S; Bordessoule D; Mairesse J; Gelsi-Boyer V; Cheze S; Beyne-Rauzy O; Sébert M; Sapena R; Zerazhi H; Legros L; Guerci-Bresler A; Amé SN; Germing U; Santini V; Salvi F; Gioia D; Lunghi M; Dreyfus F; Fenaux P;

Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients. in Blood / Blood. 2014 Nov 6;124(19):2930-6. doi: 10.1182/blood-2014-06-583021. Epub 2014 Sep 16.

2014
AOU Novara

Barcellini W; Fattizzo B; Zaninoni A; Radice T; Nichele I; Di Bona E; Lunghi M; Tassinari C; Alfinito F; Ferrari A; Leporace AP; Niscola P; Carpenedo M; Boschetti C; Revelli N; Villa MA; Consonni D; Scaramucci L; De Fabritiis P; Tagariello G; Gaidano G; Rodeghiero F; Cortelezzi A; Zanella A;

Derivative (1)t(1;16)(p11;p11.1) in myelodysplastic syndrome: a case report and review of the literature. in Cancer genetics and cytogenetics / Cancer Genet Cytogenet. 2010 Jan 1;196(1):89-92. doi: 10.1016/j.cancergencyto.2009.07.003.

2010
AOU Novara

Lunghi M; Casorzo L; De Paoli L; Riccomagno P; Rossi D; Gaidano G;

Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome. in British journal of haematology / Br J Haematol. 2008 Jun;142(2):202-15. doi: 10.1111/j.1365-2141.2008.07166.x. Epub 2008 May 19.

2008
AOU Novara

Rossi D; Cerri M; Capello D; Deambrogi C; Rossi FM; Zucchetto A; De Paoli L; Cresta S; Rasi S; Spina V; Franceschetti S; Lunghi M; Vendramin C; Bomben R; Ramponi A; Monga G; Conconi A; Magnani C; Gattei V; Gaidano G;

Prevalence and clinical characteristics of immune thrombocytopenic purpura in a cohort of monoclonal gammopathy of uncertain significance. in British journal of haematology / Br J Haematol. 2007 Jul;138(2):249-52. doi: 10.1111/j.1365-2141.2007.06633.x. Epub 2007 May 29.

2007
AOU Novara

Rossi D; De Paoli L; Franceschetti S; Capello D; Vendramin C; Lunghi M; Conconi A; Magnani C; Gaidano G;

Transient monoclonal expansion of CD8+/CD57+ T-cell large granular lymphocytes after primary cytomegalovirus infection. in American journal of hematology / Am J Hematol. 2007 Dec;82(12):1103-5. doi: 10.1002/ajh.20981.

2007
AOU Novara

Rossi D; Franceschetti S; Capello D; De Paoli L; Lunghi M; Conconi A; Gaidano G;